-
Report details
-
16
Figures
-
11
Tables
-
Chapter 1: Executive Summary
-
Current Trends
-
Scope and Methodology
-
Chapter 2: Market Development and Trends
-
Sequencer Market Stable But Poised for Changes
-
Major Vendors’ Sequencer Systems and Performance
-
Deals
-
Trends
-
Clinical Applications
-
Liquid Biopsy, Circulating Nucleic Acids
-
Regulatory and Standardization Efforts
-
Increased Access Through Decentralization
-
Potential for Increasing Competition
-
Advancements in NGS Technology
-
Long-Read Sequencing
-
Single Cell Sequencing
-
Epigenetic Sequencing
-
High-Throughput Sequencing
-
Real-time Sequencing
-
Portable Sequencing Devices
-
Direct RNA Sequencing
-
Spatial Transcriptomics
-
Metagenomics, Microbiome
-
Multi-Omics Integration
-
Chapter 3: Market Analysis
-
Overview
-
Sequencer Market by Product Types
-
Sequencer Market by Country and Region
-
Market Shares
-
Chapter 4: Company Profiles
-
10X Genomics
-
Agilent Technologies
-
BGI (Beijing Genomics Inst.)
-
Prenatal Testing
-
Test Services
-
Whole Genome Sequencing (WGS)
-
NGS Sequencing
-
Collaborations
-
Berry Genomics
-
CareDx
-
Testing Services Offered by CareDx
-
Products Offered by CareDx
-
Element Biosciences
-
Exact Sciences
-
Recent Revenues and Developments
-
Illumina
-
Diagnostics
-
Other Collaborations and Announcements
-
China
-
New England Biolabs
-
Oxford Nanopore Technologies
-
Pacific Biosciences (PacBio)
-
Background and Other Announcements
-
Qiagen
-
Revvity
-
Sequencing/Genomics
-
Liquid Biopsy
-
Prenatal Business
-
Lab Services
-
Singular Genomic
-
Takara Bio
-
Tecan
-
Thermo Fisher Scientific
-
Next-Generation Sequencing
-
Transplant Medicine
-
Microbiome
-
Other Collaborations and Acquisitions
-
Gene Editing and Cell Therapy
-
Ultima Genomics
|
Worldwide Sequencer Market, 2023-2028
7 Aug 2024
Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.
The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the DNA and RNA sequencing process."
Kalorama Information has been closely monitoring the market for next-generation sequencing (NGS) systems since their inception. The report discusses the rapid growth and transformation of the sequencing market over the past decade, driven by technological advancements, expanding applications, and decreasing costs. It provides comprehensive insights into market share, revenue growth, competitive dynamics, and company profiles.
NGS technology has become a staple in the life sciences, offering significant improvements in performance and output while reducing costs in line with Moore's Law. Some systems now enable genome sequencing at costs as low as $100-$200. The technology is widely used for applications including:
- Whole genome sequencing
- Targeted/amplicon resequencing
- Exome sequencing
- SNP analysis
- RNA sequencing
- Gene expression profiling
- Transcriptomics
- Small RNA/miRNA analysis
- ChIP-seq
- Methylation analysis
- Metagenomics
Worldwide Sequencer Market, 2023-2028 provides a comprehensive overview of these applications and examines the trends and challenges shaping the future of the sequencing market.
Page Count: 132
Table of Contents
-
Chapter 1: Executive Summary
-
Current Trends
-
Scope and Methodology
-
Chapter 2: Market Development and Trends
-
Sequencer Market Stable But Poised for Changes
-
Major Vendors’ Sequencer Systems and Performance
-
Deals
-
Trends
-
Clinical Applications
-
Liquid Biopsy, Circulating Nucleic Acids
-
Regulatory and Standardization Efforts
-
Increased Access Through Decentralization
-
Potential for Increasing Competition
-
Advancements in NGS Technology
-
Long-Read Sequencing
-
Single Cell Sequencing
-
Epigenetic Sequencing
-
High-Throughput Sequencing
-
Real-time Sequencing
-
Portable Sequencing Devices
-
Direct RNA Sequencing
-
Spatial Transcriptomics
-
Metagenomics, Microbiome
-
Multi-Omics Integration
-
Chapter 3: Market Analysis
-
Overview
-
Sequencer Market by Product Types
-
Sequencer Market by Country and Region
-
Market Shares
-
Chapter 4: Company Profiles
-
10X Genomics
-
Agilent Technologies
-
BGI (Beijing Genomics Inst.)
-
Prenatal Testing
-
Test Services
-
Whole Genome Sequencing (WGS)
-
NGS Sequencing
-
Collaborations
-
Berry Genomics
-
CareDx
-
Testing Services Offered by CareDx
-
Products Offered by CareDx
-
Element Biosciences
-
Exact Sciences
-
Recent Revenues and Developments
-
Illumina
-
Diagnostics
-
Other Collaborations and Announcements
-
China
-
New England Biolabs
-
Oxford Nanopore Technologies
-
Pacific Biosciences (PacBio)
-
Background and Other Announcements
-
Qiagen
-
Revvity
-
Sequencing/Genomics
-
Liquid Biopsy
-
Prenatal Business
-
Lab Services
-
Singular Genomic
-
Takara Bio
-
Tecan
-
Thermo Fisher Scientific
-
Next-Generation Sequencing
-
Transplant Medicine
-
Microbiome
-
Other Collaborations and Acquisitions
-
Gene Editing and Cell Therapy
-
Ultima Genomics
|
More information about this product
Other Users Also Viewed
26 Jul 2024
Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and…
|